Limited role of inducible nitric oxide synthase in blood-brain barrier function after experimental subarachnoid hemorrhage

Journal of Neurotrauma

Volumn 23, Issue 12, 2006, Pages 1874-1882

  Yatsushige, Hiroshi ^a,c   Calvert, John W ^a,c   Cahill, Julian ^a   Zhang, John H ^a,b,c  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^c Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Inducible nitric oxide synthase; Nitric oxide; Subarachnoid hemorrhage

Indexed keywords

4 TOLUENESULFONATE; IMMUNOGLOBULIN G; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SULFONIC ACID DERIVATIVE; TOLUENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME INHIBITION; INTERNAL CAROTID ARTERY; MALE; METABOLITE; MORPHOLOGY; MORTALITY; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SUBARACHNOID HEMORRHAGE; WATER CONTENT;

ANIMALS; BENZENESULFONATES; BLOOD-BRAIN BARRIER; BRAIN EDEMA; DISEASE MODELS, ANIMAL; MALE; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE;

EID: 33845952417     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2006.23.1874     Document Type: Article

References (37)

1. BEDERSON, J.B., GERMANO, I.M., and GUARINO, L. (1995). Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 26, 1086-1091.
2. BOJE, K.M., and ARORA, P.K. (1992). Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587, 250-256.
3. BUCCI, M., ROVIEZZO, F., POSADAS, I., et al., (2005). Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc. Natl. Acad. Sci. USA 102, 904-908.
4. CALVERT, J.W., and ZHANG, J.H. (2005). Pathophysiology of an hypoxic-ischemic insult during the perinatal period. Neurol. Res. 27, 246-260.
5. DINGMAN, A., LEE, S.Y., DERUGIN, N., WENDLAND, M.F., and VEXLER, Z.S. (2006). Aminoguanidine inhibits caspase-3 and calpain activation without affecting microglial activation following neonatal transient cerebral ischemia. J. Neurochem. 96, 1467-1479.
6. GARCIA, J.H., WAGNER, S., LIU, K.F., and HU, X.J. (1995). Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26, 627-634.
7. IADECOLA, C., ZHANG, P., CASEY, R., CLARK, H.B., and ROSS, M.E. (1996). Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 27, 1373-1380.
8. JACKOWSKI, A., CROCKARD, A., BURNSTOCK, G., RUSSELL, R.R., and KRISTEK, F. (1990). The time course of intracranial pathophysiological changes following experimental subarachnoid haemorrhage in the rat. J. Cereb. Blood Flow Metab. 10, 835-849.
9. JONES, N.C., CONSTANTIN, D., GIBSON, C.L., et al. (2004). A detrimental role for nitric oxide synthase-2 in the pathology resulting from acute cerebral injury. J. Neuropathol. Exp. Neurol. 63, 708-720.
10. KHALDI, A., ZAUNER, A., REINERT, M., WOODWARD, J.J., and BULLOCK, M.R. (2001). Measurement of nitric oxide and brain tissue oxygen tension in patients after severe subarachnoid hemorrhage. Neurosurgery 49, 33-38.
11. KLEINERT, H., PAUTZ, A., LINKER, K., and SCHWARZ, P.M. (2004). Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 500, 255-266.
12. KUBES, P., and GRANGER, D.N. (1992). Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262, H611-H615.
13. KUSAKA, G., ISHIKAWA, M., NANDA, A., GRANGER, D.N., and ZHANG, J.H. (2004). Signaling pathways for early brain injury after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 24, 916-925.
14. LOUIN, G., MARCHAND-VERRECCHIA, C., PALMIER, B., PLOTKINE, M., and JAFARIAN-TEHRANI, M. (2005). Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury. Neuropharmacology 50, 182-190.
15. MARK, K.S., BURROUGHS, A.R., BROWN, R.C., HUBER, J.D., and DAVIS, T.P. (2004). Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature. Am. J. Physiol. Heart Circ. Physiol. 286, H174-H180.
16. MAYHAN, W.G. (1995). Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. Brain Res. 686, 99-103.
17. McQUEEN, J.D., NORTHRUP, B.E., LEIBROCK, L.G., and MOROONEY, K. (1971). The sealing action of subarachnoid blood. Acta Neurol. Latinoam. 1, Suppl, 98.
18. NAG, S., PICARD, P., and STEWART, D.J. (2000). Increased immunolocalization of nitric oxide synthases during blood-brain barrier breakdown and cerebral edema. Acta Neurochir. Suppl. 76, 65-68.
19. NAG, S., PICARD, P., and STEWART, D.J. (2001). Expression of nitric oxide synthases and nitrotyrosine during blood-brain barrier breakdown and repair after cold injury. Lab. Invest. 81, 41-49.
20. NG, W.H., MOOCHHALA, S., YEO, T.T., ONG, P.L., and NG, P.Y. (2001). Nitric oxide and subarachnoid hemorrhage: elevated level in cerebrospinal fluid and their implications. Neurosurgery 49, 622-626.
21. PARK, S., YAMAGUCHI, M., ZHOU, C., CALVERT, J.W., TANG, J., and ZHANG, J.H. (2004). Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 35, 2412-2417.
22. PEARSE, D.D., CHATZIPANTELI, K., MARCILLO, A.E., BUNGE, M.B., and DIETRICH, W.D. (2003). Comparison of iNOS inhibition by antisense and pharmacological inhibitors after spinal cord injury. J. Neuropathol. Exp. Neurol. 62, 1096-1107.
23. PLUTA, R.M. (2005). Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol. Ther. 105, 23-56.
24. RICHMON, J.D., FUKUDA, K., MAIDA, N., et al. (1998). Induction of heme oxygenase-1 after hyperosmotic opening of the blood-brain barrier. Brain Res. 780, 108-118.
25. RUETTEN, H., SOUTHAN, G.J., ABATE, A., and THIEMERMANN, C. (1996). Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br. J. Pharmacol. 118, 261-270.
26. SAITO, A., KAMII, H., KATO, I., et al. (2001). Transgenic CuZn-superoxide dismutase inhibits NO synthase induction in experimental subarachnoid hemorrhage. Stroke 32, 1652-1657.
27. SAYAMA, T., SUZUKI, S., and FUKUI, M. (1998). Expression of inducible nitric oxide synthase in rats following subarachnoid hemorrhage. Neurol. Res. 20, 79-84.
28. SAYAMA, T., SUZUKI, S., and FUKUI, M. (1999). Role of inducible nitric oxide synthase in the cerebral vasospasm after subarachnoid hemorrhage in rats. Neurol. Res. 21, 293-298.
29. SEHBA, P.A., SCHWARTZ, A.Y., CHERESHNEV, I., and BEDERSON, J.B. (2000). Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 20, 604-611.
30. SHARMA, H.S., DRIEU, K., ALM, P., and WESTMAN, J. (2000). Role of nitric oxide in blood-brain barrier permeability, brain edema and cell damage following hyperthermic brain injury. An experimental study using EGB-761 and Gingkolide B pretreatment in the rat. Acta Neurochir. Suppl. 76, 81-86.
31. SINZ, E.H., KOCHANEK, P.M., DIXON, C.E., et al. (1999). Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J. Clin. Invest. 104, 647-656.
32. TROJANOWSKI, T. (1984). Early effects of experimental arterial subarachnoid haemorrhage on the cerebral circulation. Part I: Experimental subarachnoid haemorrhage in cat and its pathophysiological effects. Methods of regional cerebral blood flow measurement and evaluation of microcirculation. Acta Neurochir. (Wien.) 72, 79-94.
33. WELLER, R. (2003). Nitric oxide: a key mediator in cutaneous physiology. Clin. Exp. Dermatol. 28, 511-514.
34. WIDENKA, D.C., MEDELE, R.J., STUMMER, W., BISE, K., and STEIGER, H.J. (1999). Inducible nitric oxide synthase: a possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage. J. Neurosurg. 90, 1098-1104.
35. WILLMOT, M., GIBSON, C., GRAY, L., MURPHY, S., and BATH, P. (2005). Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic. Biol. Med. 39, 412-425.
36. ZHANG, F., CASEY, R.M., ROSS, M.E., and IADECOLA, C. (1996). Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke 27, 317-323.
37. ZHOU, C., LI, Y., NANDA, A., and ZHANG, J.H. (2003). HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischemia. Biochem. Biophys. Res. Commun. 309, 368-376.